Rocket Pharmaceuticals (RCKT) Other Non-Current Liabilities (2014 - 2026)
Rocket Pharmaceuticals (RCKT) recorded Other Non-Current Liabilities of $1.13 million in Q2 2026, up 6.4% from $1.06 million a year earlier and up 6.3% from the prior quarter.
Powered by 
Analysis
Rocket Pharmaceuticals (RCKT) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends
At the end of FY2025, Rocket Pharmaceuticals reported Other Non-Current Liabilities of $1.06 million, down 7.1% from FY2024.
- Annual Other Non-Current Liabilities has a five-year compound annual growth rate of 50.8% (FY2020 to FY2025).
- Across earlier years, Other Non-Current Liabilities came in at $1.14 million in FY2024 (-61.1%), $2.94 million in FY2023 (+13.1%), $2.6 million in FY2022 and $80,000 in FY2021 (-41.2%).
- The Q2 2026 figure is the highest quarterly Other Non-Current Liabilities since Q1 2025.
- On a year-over-year basis, Other Non-Current Liabilities rose in 1 of the last eight quarters, with an average decline of 21.2%.
- Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 308.7% in Q3 2021, against a decline of 61.1% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.06 million (Q1 2026), $1.06 million (Q4 2025) and $1.06 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,172.00 Bn | 1,140.58 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 639.12 Bn | 557.64 Bn | 17.26 Bn |
| 3 | AbbVie | 502.23 Bn | 475.34 Bn | 12.70 Bn |
| 4 | Merck | 375.29 Bn | 329.67 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.99 Bn | 266.98 Bn | 11.24 Bn |
| 6 | Astrazeneca | 268.68 Bn | 242.36 Bn | 12.86 Bn |
| 7 | Amgen | 242.24 Bn | 197.64 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.36 Bn | 167.56 Bn | 6.22 Bn |
| 9 | Pfizer | 172.57 Bn | 119.21 Bn | 10.94 Bn |
| 10 | Rocket Pharmaceuticals | 254.47 Mn | -29.23 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.13 Mn |
| Mar 31, 2026 | 1.06 Mn |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 1.06 Mn |
| Mar 31, 2025 | 1.14 Mn |
| Dec 31, 2024 | 1.14 Mn |
| Sep 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 1.25 Mn |
| Mar 31, 2024 | 1.91 Mn |
| Dec 31, 2023 | 2.94 Mn |
| Sep 30, 2023 | 1.87 Mn |
| Jun 30, 2023 | 2.07 Mn |
| Mar 31, 2023 | 1.88 Mn |
| Dec 31, 2022 | 2.60 Mn |
| Sep 30, 2022 | 37,000.00 |
| Jun 30, 2022 | 51,000.00 |
| Mar 31, 2022 | 65,000.00 |
| Dec 31, 2021 | 80,000.00 |
| Sep 30, 2021 | 94,000.00 |
API Access
Rocket Pharmaceuticals Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RCKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "RCKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RCKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();